Fig. 2From: PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinomaPerformances of PIVKA-II and AFP in the diagnosis of HCC as individual biomarkers. ROC to distinguish HCC from healthy controls (HC) (a, b), HCC from benign liver diseases (BLD) (c, d)Back to article page